[go: up one dir, main page]

MA30993B1 - Adsorbant des phosphates a base de glucide et de fer(iii) - Google Patents

Adsorbant des phosphates a base de glucide et de fer(iii)

Info

Publication number
MA30993B1
MA30993B1 MA31992A MA31992A MA30993B1 MA 30993 B1 MA30993 B1 MA 30993B1 MA 31992 A MA31992 A MA 31992A MA 31992 A MA31992 A MA 31992A MA 30993 B1 MA30993 B1 MA 30993B1
Authority
MA
Morocco
Prior art keywords
iron
carbohydrum
iii
phosphate adsorbent
adsorbent based
Prior art date
Application number
MA31992A
Other languages
English (en)
Inventor
Michael Ambuehl
Corine Gessier-Vial
Christa Hartmann
Daniel Kaufmann
Ernst Kuesters
Ulrich Meier
Andreas Meyer
Nabila Sekkat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38983614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30993(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06126122A external-priority patent/EP1932807A1/fr
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA30993B1 publication Critical patent/MA30993B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/223—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material containing metals, e.g. organo-metallic compounds, coordination complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/2803—Sorbents comprising a binder, e.g. for forming aggregated, agglomerated or granulated products
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/0018—Mixed oxides or hydroxides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/02—Oxides; Hydroxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE UN NOUVEL ADSORBANT DES PHOSPHATES CONTENANT DU FER ET L'UTILISATION DE CELUI-CI, PAR EXEMPLE POUR TRAITER L'HYPERPHOSPHATÉMIE.
MA31992A 2006-12-14 2009-06-15 Adsorbant des phosphates a base de glucide et de fer(iii) MA30993B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126122A EP1932807A1 (fr) 2006-12-14 2006-12-14 Composés inorganiques
EP06126101 2006-12-14

Publications (1)

Publication Number Publication Date
MA30993B1 true MA30993B1 (fr) 2009-12-01

Family

ID=38983614

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31992A MA30993B1 (fr) 2006-12-14 2009-06-15 Adsorbant des phosphates a base de glucide et de fer(iii)

Country Status (23)

Country Link
US (2) US8252310B2 (fr)
JP (1) JP5456969B2 (fr)
KR (1) KR20090094820A (fr)
AR (1) AR064301A1 (fr)
AU (1) AU2007331482B2 (fr)
BR (1) BRPI0720272A2 (fr)
CA (1) CA2671828C (fr)
CL (1) CL2007003606A1 (fr)
EC (1) ECSP099410A (fr)
ES (1) ES2526171T3 (fr)
IL (1) IL198548A0 (fr)
MA (1) MA30993B1 (fr)
MX (1) MX2009006307A (fr)
MY (1) MY151047A (fr)
NO (1) NO342285B1 (fr)
NZ (1) NZ576672A (fr)
PE (1) PE20081381A1 (fr)
PT (1) PT2319804E (fr)
RU (1) RU2447933C2 (fr)
SI (1) SI2319804T1 (fr)
TN (1) TN2009000214A1 (fr)
TW (1) TWI465239B (fr)
WO (1) WO2008071747A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
JP2009292119A (ja) 2008-06-09 2009-12-17 Alps Electric Co Ltd サーマルヘッド
CN102089075B (zh) * 2008-06-13 2013-04-24 诺瓦提斯公司 用于制备含铁的磷酸盐吸附剂的制备方法
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
BR112012001372A2 (pt) * 2009-07-21 2016-12-27 Keryx Biopharmaceuticals Inc comprimido, e, métodos para preparar um comprimido e para a profilaxia ou tratamento de hiperfosfatemia.
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
WO2013056085A1 (fr) * 2011-10-13 2013-04-18 Vidasym, Inc. Composition de fibre de fer, sa préparation et ses utilisations
RU2496722C1 (ru) * 2012-04-10 2013-10-27 Леонид Асхатович Мазитов Способ очистки сточной воды от фосфатов
CN109497565B (zh) 2013-03-08 2021-10-26 上海礼邦医药科技有限公司 金属离子-功能性纤维组分络合物组合物、其制备及用途
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
AU2014228990B2 (en) * 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam
SMT202000461T1 (it) * 2013-11-27 2021-05-07 Vifor Int Ag Composizione farmaceutica, comprendente particelle leganti fosfato
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US9901918B2 (en) 2015-03-04 2018-02-27 Graver Technologies Llc Hybrid ion exchange material and method for making the same
CN105193844A (zh) * 2015-05-27 2015-12-30 合肥川迪医药技术有限公司 用于制备含δ-羟基氧化铁(多核)及其药物组合物的方法及在高磷血症领域中的应用
WO2017172633A1 (fr) * 2016-03-28 2017-10-05 New Sky Energy Intellectual Property Holding Company, Llc Procédés de production de bouillies de nanoparticules de ferrihydrite, et systèmes et produits les utilisant
EP3829761A1 (fr) 2018-07-30 2021-06-09 Interquim S.A. Processus de préparation d'un adsorbant de phosphate en milieu aqueux
CA3163438A1 (fr) 2020-01-16 2021-07-22 Vifor Fresenius Medical Care Renal Pharma, Ltd. Particules d'un melange d'oxyhydroxyde de fer (iii), de saccharose et d'un ou plusieurs amidons, de preference d'oxyhydroxyde sucroferrique
CN115317494B (zh) * 2022-07-22 2024-02-13 康瑞鑫(天津)药物研究院有限公司 高磷酸盐结合力的蔗糖氢氧化氧铁及其制备方法
WO2025096992A1 (fr) * 2023-11-01 2025-05-08 Navinta, Llc Procédé d'isolement de dérisomaltose ferrique solide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885393A (en) * 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3697502A (en) * 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4569836A (en) * 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
EP0330801A1 (fr) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Particules ferromagnétiques, diamagnétiques ou paramagnétiques avantageuses dans le diagnostic et le traitement des maladies
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
US4970079A (en) 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
SU1807606A1 (ru) * 1991-03-29 1995-08-09 Пермский политехнический институт Способ получения анионообменника на основе гидроксида титана
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
EP0585898B1 (fr) 1992-09-04 1998-08-05 Mitsubishi Chemical Corporation Procédé de fabrication et utilisation d'une résine échangeuse d' anions
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
DE10128511A1 (de) * 2001-06-13 2002-12-19 Sebo Gmbh Verwendung eines Phosphatadsorbers gegen Gefäßerkrankungen
CN1606472A (zh) 2001-12-21 2005-04-13 室町化学株式会社 磷酸吸附剂
DE102004031181A1 (de) 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens

Also Published As

Publication number Publication date
HK1133248A1 (en) 2010-03-19
ECSP099410A (es) 2009-07-31
CA2671828A1 (fr) 2008-06-19
US20120126440A1 (en) 2012-05-24
RU2447933C2 (ru) 2012-04-20
RU2009126614A (ru) 2011-01-20
JP2008150375A (ja) 2008-07-03
NO342285B1 (no) 2018-04-30
ES2526171T3 (es) 2015-01-07
NO20092632L (no) 2009-07-14
PT2319804E (pt) 2014-11-24
SI2319804T1 (sl) 2015-01-30
TWI465239B (zh) 2014-12-21
TN2009000214A1 (en) 2010-10-18
MY151047A (en) 2014-03-31
US20080145410A1 (en) 2008-06-19
AU2007331482B2 (en) 2011-04-21
BRPI0720272A2 (pt) 2014-01-28
KR20090094820A (ko) 2009-09-08
CA2671828C (fr) 2012-06-19
JP5456969B2 (ja) 2014-04-02
US8252310B2 (en) 2012-08-28
AU2007331482A1 (en) 2008-06-19
IL198548A0 (en) 2010-02-17
PE20081381A1 (es) 2008-11-12
MX2009006307A (es) 2009-06-23
WO2008071747A1 (fr) 2008-06-19
CL2007003606A1 (es) 2008-07-18
NZ576672A (en) 2012-02-24
TW200831115A (en) 2008-08-01
AR064301A1 (es) 2009-03-25

Similar Documents

Publication Publication Date Title
MA30993B1 (fr) Adsorbant des phosphates a base de glucide et de fer(iii)
GB2431953A (en) Radial expansion system
MXPA05010706A (es) Uso de un inhibidor del transporte de acido biliar ileal (ibat) para el tratamiento o profilaxis del estrenimiento.
TW200710984A (en) Plasma processing system and baffle assembly for use in plasma processing system
AR069859A1 (es) Tratamiento de biocombustibles
BRPI0808100A2 (pt) Corpo de eixo
ATE533101T1 (de) Bedienvorrichtung
AU301839S (en) Pipe gland ear
JO2242B1 (en) Phosphatase inhibitors
CA118531S (en) Electronic media player/storage
AU302772S (en) Pipe gland ear
BRPI0606122A2 (pt) tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal
SI1831209T1 (sl) Zaviralci fosfataz cdc25
AU321249S (en) An instrument cluster for an automobile
ATE494472T1 (de) Abgasrückführsystem
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
AP2003002855A0 (en) Inhibitor of monoamine uptake.
TW200513587A (en) Gas directing system and method
EA200700681A1 (ru) Активирующие агенты для металлоценовых компонентов на основе гафния
AU301840S (en) Pipe gland ear
GB2433942A (en) Method and plant for transport of rich gas
IL181183A0 (en) Enzyme inhibitor in leukemia
EA200602009A1 (ru) Выпускная труба
ATE551776T1 (de) Kompandersystem
DE50310896D1 (de) Regneranordnung